Acquired sideroblastic anaemia after aplastic anaemia caused by D-penicillamine therapy for rheumatoid arthritis

Ann Rheum Dis. 1987 Feb;46(2):156-8. doi: 10.1136/ard.46.2.156.

Abstract

A 68 year old man with rheumatoid arthritis developed marrow aplasia during D-penicillamine treatment. Recovery of granulopoiesis and erythropoiesis was ineffective with features of a secondary sideroblastic anaemia. Absence of megakaryopoiesis persisted. Therapeutic measures failed, and the patient finally died. These events illustrate a haematopoietic stem cell injury induced by D-penicillamine.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anemia, Aplastic / chemically induced
  • Anemia, Sideroblastic / chemically induced*
  • Arthritis, Rheumatoid / drug therapy*
  • Humans
  • Male
  • Penicillamine / adverse effects*

Substances

  • Penicillamine